New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3β signaling DOI Creative Commons
Jiajia Lu, Xiaojian Shi, Qiang Fu

et al.

Cellular & Molecular Biology Letters, Journal Year: 2024, Volume and Issue: 29(1)

Published: July 8, 2024

Abstract Objective Osteoporosis is a global health issue characterized by decreased bone mass and microstructural degradation, leading to an increased risk of fractures. This study aims explore the molecular mechanism which P2X7 receptors influence osteoclast formation resorption through PI3K-Akt-GSK3β signaling pathway. Methods An osteoporosis mouse model was generated ovariectomy (OVX) in normal C57BL/6 f/f ; LysM-cre mice. Osteoclasts were isolated for transcriptomic analysis, differentially expressed genes selected functional enrichment analysis. Metabolite analysis performed using liquid chromatography-tandem spectrometry (LC–MS/MS), multivariate statistical pattern recognition used identify differential lipid metabolism markers their distribution. Bioinformatics analyses conducted Encyclopedia Genes Genomes database MetaboAnalyst assess potential biomarkers create metabolic pathway map. Osteoclast precursor cells vitro cell experiments, evaluating viability proliferation Cell Counting Kit 8 (CCK-8) assay. induced differentiate into osteoclasts macrophage colony-stimulating factor (M-CSF) receptor activator nuclear kappa-beta ligand (RANKL), tartrate-resistant acid phosphatase (TRAP) staining compare differentiation morphology, size, quantity between different groups. Western blot expression markers, fusion gene ability osteoclasts. Immunofluorescence employed examine spatial distribution skeletons, protein, nuclei, while pit assay evaluate ability. Finally, vivo animal including micro computed tomography (micro-CT), hematoxylin eosin (HE) staining, TRAP immunohistochemistry, observe tissue differentiation, phosphorylation level Results Transcriptomic metabolomic data collectively reveal that can impact pathogenesis Subsequent experiments showed Sh-P2X7 + Recilisib group exhibited proliferative activity (1.15 versus 0.59), higher absorbance levels (0.68 0.34), significant increase area (13.94 3.50). Expression differentiation-related proteins MMP-9, CK, NFATc1 markedly elevated (MMP-9: 1.72 0.96; CK: 2.54 0.95; NFATc1: 3.05 0.95), along with fluorescent intensity F-actin rings. In contrast, OE-P2X7 LY294002 (0.64 1.29), reduced (0.34 0.82), decrease (5.01 14.96), accompanied weakened 1.14 1.79; 1.26 2.75; 1.17 2.90) intensity. Furthermore, demonstrated compared wild type (WT) Sham group, mice WT OVX significantly CTX NTX serum (CTX: 587.17 129.33; NTX: 386.00 98.83), notable calcium deposition (19.67 53.83), reduction density, trabecular separation, lowered mineral density (BMD). When KO recilisib substantial 503.50 209.83; 339.83 127.00), further (29.67 45.33), as well BMD. Conclusion positively regulate activating

Language: Английский

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study DOI Creative Commons
Yanlin Wu, Zhengjun Lin, Changchun Li

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: March 2, 2023

Abstract Epigenetics regulates gene expression and has been confirmed to play a critical role in variety of metabolic diseases, such as diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), osteoporosis, gout, hyperthyroidism, hypothyroidism others. The term ‘epigenetics’ was firstly proposed 1942 with the development technologies, exploration epigenetics made great progresses. There are four main epigenetic mechanisms, including DNA methylation, histone modification, chromatin remodelling, noncoding RNA (ncRNA), which exert different effects on diseases. Genetic non-genetic factors, ageing, diet, exercise, interact jointly affect formation phenotype. Understanding could be applied diagnosing treating diseases clinic, biomarkers, drugs, editing. In this review, we introduce brief history well milestone events since proposal ‘epigenetics’. Moreover, summarise research methods general mechanisms modulation. Furthermore, interaction between genetic or factors. Finally, clinical trials applications

Language: Английский

Citations

185

Osteoporosis pathogenesis and treatment: existing and emerging avenues DOI Creative Commons
Bo Liang, George Burley, Shu Lin

et al.

Cellular & Molecular Biology Letters, Journal Year: 2022, Volume and Issue: 27(1)

Published: Sept. 4, 2022

Abstract Osteoporotic fractures lead to increased disability and mortality in the elderly population. With rapid increase aging population around globe, more effective treatments for osteoporosis osteoporotic are urgently required. The underlying molecular mechanisms of believed be due activity osteoclasts, decreased osteoblasts, or both, which leads an imbalance bone remodeling process with accelerated resorption attenuated formation. Currently, available clinical have mostly focused on factors influencing remodeling; however, they their own limitations side effects. Recently, cytokine immunotherapy, gene therapy, stem cell therapy become new approaches treatment various diseases. This article reviews latest research mechanisms, as well how this underpins current potential novel osteoporosis.

Language: Английский

Citations

113

The role of Exosomal miRNAs in cancer DOI Creative Commons
Chuanyun Li, Tong Zhou, Jing Chen

et al.

Journal of Translational Medicine, Journal Year: 2022, Volume and Issue: 20(1)

Published: Jan. 3, 2022

Exosomal miRNAs have attracted much attention due to their critical role in regulating genes and the altered expression of virtually all cancers affecting humans (Sun et al. Mol Cancer 17(1):14, 2018). modulate processes that interfere with cancer immunity microenvironment, are significantly involved tumor growth, invasion, metastasis, angiogenesis drug resistance. Fully investigating detailed mechanism occurrence development various could help not only treatment but also prevention malignant diseases. The current review highlighted recently published advances regarding cancer-derived exosomes, e.g., sorting delivery mechanisms for RNAs. cell-to-cell communication, impacting angiogenesis, metastasis multiple biological features, were discussed. Finally, potential exosomal as diagnostic prognostic molecular markers was summarized, well usefulness detecting resistance therapeutic agents.

Language: Английский

Citations

104

Hypoxic ADSC-derived exosomes enhance wound healing in diabetic mice via delivery of circ-Snhg11 and induction of M2-like macrophage polarization DOI Open Access
Rongfeng Shi,

Yinpeng Jin,

Suming Zhao

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2022, Volume and Issue: 153, P. 113463 - 113463

Published: Aug. 5, 2022

Diabetes mellitus is a major cause of blindness and chronic ulcers in the working age population worldwide. Former research have found that differentially expressed circular RNAs (circRNAs) are associated with hyperglycemia (HG)-induced endothelial cell damage. And adipose-derived stem cells (ADSCs)-exosome transplant more therapeutic effect to enhance wound healing diabetic mice by delivery circRNA. The current investigation employed high-throughput sequencing identify circRNAs abnormally progenitor (EPCs) under HG conditions. regulatory mechanism predicted targets one circRNA, circ-Snhg11, were investigated utilizing bioinformatics analyses, luciferase reporter assays, angiogenic differentiation flow cytometric apoptosis analysis, RT-qPCR. result show circ-Snhg11 expression decreased EPCs conditions overexpression suppressed HG-induced damage M1-like macrophage polarization. miR-144-3p HIF-1α identified as downstream which was further verified analysis. or inhibition reversed protective on dysfunction, evidenced increased apoptosis, abnormal vascular differentiation, secretion inflammatory factors. In addition, regarding M2-like polarization These findings suggest promotes through sponging. Our data demonstrate exosome from ADSCs suppresses induces via miR-144-3p/HIF-1α axis.

Language: Английский

Citations

78

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis DOI Creative Commons
Giovanni Adami, Angelo Fassio, Davide Gatti

et al.

Therapeutic Advances in Musculoskeletal Disease, Journal Year: 2022, Volume and Issue: 14, P. 1759720X2210835 - 1759720X2210835

Published: Jan. 1, 2022

Patients living with osteoporosis are projected to increase dramatically in the next decade. Alongside forecasted increased societal and economic burden, we will live a crisis of fractures. However, have novel pharmacological treatment face this and, more importantly, new optimized strategies. Fracture liaison services be probably implemented on large scale worldwide, helping prevent additional fractures high-risk patients. In decade, advances diagnostic tools largely available. Moreover, precise fracture risk assessment change our ability detect patients at high Finally, big data artificial intelligence help us move forward into world precision medicine. present review, discuss future epidemiology costs osteoporosis, early accurate diagnosis special focus biomarkers imaging tools. Then examine refined tools, role services, perspective treatment.

Language: Английский

Citations

71

Obesity and lipid metabolism in the development of osteoporosis (Review) DOI Creative Commons
Xiaochuan Wang, Chi Zhang,

Guang Zhao

et al.

International Journal of Molecular Medicine, Journal Year: 2024, Volume and Issue: 54(1)

Published: May 27, 2024

Osteoporosis is a common bone metabolic disease that causes heavy social burden and seriously threatens life. Improving osteogenic capacity necessary to correct mass loss in the treatment of osteoporosis. Osteoblasts are derived from differentiation marrow mesenchymal stem cells, process opposes adipogenic differentiation. The peroxisome proliferator‑activated receptor γ Wnt/β‑catenin signaling pathways mediate mutual regulation osteogenesis adipogenesis. Lipid substances play an important role occurrence development content proportion lipids modulate activity immunocytes, mainly macrophages, secretion inflammatory factors, such as IL‑1, IL‑6 TNF‑α. These effectors increase promote osteoclasts, which leads imbalance stronger resorption. Obesity also decreases antioxidases oxidative stress, thereby inhibiting osteogenesis. present review starts by examining bidirectional BM‑MSCs, describes detail mechanism affect metabolism, discusses regulatory inflammation stress this process. concludes reasonable adjustment lipids, alleviation storms damage induced lipid imbalances, will improve treat

Language: Английский

Citations

39

Osteomyelitis and non-coding RNAS: A new dimension in disease understanding DOI
Md Sadique Hussain, Nusrat K. Shaikh, Mohit Agrawal

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 255, P. 155186 - 155186

Published: Feb. 2, 2024

Language: Английский

Citations

18

The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis DOI Creative Commons
Fei Xu, Wenhui Li, Xiao Yang

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2021, Volume and Issue: 8

Published: Jan. 25, 2021

Osteoporosis is a metabolic disease characterized by decreased bone mineral density and the destruction of microstructure, which can lead to increased fragility risk fracture. In recent years, with deepening research on pathological mechanism osteoporosis, epigenetics has made significant progress. Epigenetics refers changes in gene expression levels that are not caused sequences, mainly including DNA methylation, histone modification, non-coding RNAs (lncRNA, microRNA, circRNA). play post-transcriptional regulatory role have important functions biological signal network. Studies shown epigenetic mechanisms closely related osteogenic differentiation, osteogenesis, remodeling other metabolism-related processes. Abnormal regulation series diseases, such as osteoporosis. Considering metabolism, we review progress (DNA RNAs) differentiation pathogenesis osteoporosis provide new direction for treatment diseases.

Language: Английский

Citations

85

MiRNAs and Cancer: Key Link in Diagnosis and Therapy DOI Open Access
Yu Shi, Zihao Liu, Qun Lin

et al.

Genes, Journal Year: 2021, Volume and Issue: 12(8), P. 1289 - 1289

Published: Aug. 23, 2021

Since the discovery of first microRNA (miRNA), exploration miRNA biology has come to a new era in recent decades. Monumental studies have proven that miRNAs can be dysregulated different types cancers and roles turn out function either tumor promoters or suppressors. The interplay between development grabbed attention as novel tools targets for therapeutic attempts. Moreover, delivery system accelerates preclinical implications. In this review, we depict advances cancer discuss potential diagnostic approaches miRNAs.

Language: Английский

Citations

84

Effects of BMSC-Derived EVs on Bone Metabolism DOI Creative Commons
Xuchang Zhou, Hong Cao,

Jianming Guo

et al.

Pharmaceutics, Journal Year: 2022, Volume and Issue: 14(5), P. 1012 - 1012

Published: May 8, 2022

Extracellular vesicles (EVs) are small membrane that can be secreted by most cells. EVs released into the extracellular environment through exocytosis, transporting endogenous cargo (proteins, lipids, RNAs, etc.) to target cells and thereby triggering release of these biomolecules participating in various physiological pathological processes. Among them, derived from bone marrow mesenchymal stem (BMSC-EVs) have similar therapeutic effects BMSCs, including repairing damaged tissues, inhibiting macrophage polarization promoting angiogenesis. In addition, BMSC-EVs, as efficient feasible natural nanocarriers for drug delivery, advantages low immunogenicity, no ethical controversy, good stability easy storage, thus providing a promising strategy many diseases. particular, BMSC-EVs show great potential treatment metabolic This article reviews mechanism formation resorption, which provides new insights future research on strategies

Language: Английский

Citations

52